Implantica launches RefluxStop in US after FDA approval
Bitget2026/09/29 06:02- Implantica launched its RefluxStop implant in the US at the 2026 American Foregut Society meeting in Washington, D.C.
- Commercial rollout started following FDA PMA clearance, marking the company’s entry into the US GERD surgery market.
- Management shifted focus to a systematic US expansion, targeting adoption by major medical centers.
- The launch event drew more than 120 clinicians, with nearly 30 follow-up meetings to support new site onboarding.
Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.
You may also like
Production Increase Falls Short, Layoffs First! Boeing (BA.US) Cuts 5% of Commercial Airplane Jobs, Delays 737 Monthly Production Target of 47 Aircraft to 2027
Stephanie Pope, head of Boeing's commercial airplanes division, informed employees in an internal memo on Monday that due to obstacles in increasing aircraft production, the division plans to cut 5% of its workforce.
After acquiring SpotHero, Uber (UBER.US) makes its debut in the parking sector with a parking space reservation feature, initially available in 15 U.S. cities
Uber has launched a brand new parking space reservation feature, which marks its first step in the parking sector following its acquisition of the parking app SpotHero earlier this year.
Crypto prices
More
